| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1018257615 |
| P356 | DOI | 10.1007/S00223-013-9749-Z |
| P698 | PubMed publication ID | 23748710 |
| P50 | author | Maurizio Rossini | Q41067734 |
| davide gatti | Q58150575 | ||
| Silvano Adami | Q114314176 | ||
| P2860 | cites work | A histone lysine methyltransferase activated by non-canonical Wnt signalling suppresses PPAR-gamma transactivation | Q56741581 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 121-132 | |
| P577 | publication date | 2013-06-11 | |
| P1433 | published in | Calcified Tissue International | Q5018771 |
| P1476 | title | Involvement of WNT/β-catenin signaling in the treatment of osteoporosis | |
| P478 | volume | 93 |
| Q35739047 | A comparison of tissue engineering based repair of calvarial defects using adipose stem cells from normal and osteoporotic rats |
| Q28247445 | A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density |
| Q92512052 | A soluble bone morphogenetic protein type 1A receptor fusion protein treatment prevents glucocorticoid-Induced bone loss in mice |
| Q41453417 | Adenosine Receptor Stimulation Improves Glucocorticoid-Induced Osteoporosis in a Rat Model |
| Q46282119 | Adverse Effects of Osteocytic Constitutive Activation of ß-Catenin on Bone Strength and Bone Growth |
| Q92967940 | Angelica polysaccharide promotes proliferation and osteoblast differentiation of mesenchymal stem cells by regulation of long non-coding RNA H19: An animal study |
| Q88950396 | Apelin-13 deficiency alters cortical bone geometry, organic bone matrix, and inhibits Wnt/β-catenin signaling |
| Q38343436 | Bisphosphonates in the treatment of glucocorticoid-induced osteoporosis: pros |
| Q47229430 | Bone Geometry, Quality, and Bone Markers in Children with Type 1 Diabetes Mellitus |
| Q50928427 | Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis. |
| Q91671886 | Bone turnover rate and bone formation/resorption balance during the early stage after switching from a bone resorption inhibitor to denosumab are predictive factors of bone mineral density change |
| Q92889775 | Calcitonin protects rat chondrocytes from IL-1β injury via the Wnt/β-catenin pathway |
| Q51216875 | Circulating Dickkopf-1 and sclerostin in patients with Paget's disease of bone. |
| Q48045132 | Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease |
| Q36473722 | Curcumin alleviates glucocorticoid-induced osteoporosis through the regulation of the Wnt signaling pathway |
| Q47104810 | Cyclophosphamide causes osteoporosis in C57BL/6 male mice: suppressive effects of cyclophosphamide on osteoblastogenesis and osteoclastogenesis |
| Q51707392 | Decreased Plasma Levels of Sclerostin But Not Dickkopf-1 are Associated with an Increased Prevalence of Osteoporotic Fracture and Lower Bone Mineral Density in Postmenopausal Korean Women. |
| Q90303742 | Denosumab in the treatment of glucocorticoid-induced osteoporosis |
| Q34545263 | Denosumab: targeting the RANKL pathway to treat rheumatoid arthritis. |
| Q48331932 | Dental and extra-oral clinical features in 41 patients with WNT10A gene mutations: A multicentric genotype-phenotype study |
| Q33564617 | Developments in sclerostin biology: regulation of gene expression, mechanisms of action, and physiological functions |
| Q51307682 | Dickkopf-1 and sclerostin serum levels in patients with systemic mastocytosis. |
| Q34506361 | Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis |
| Q33740634 | Dose-dependent effect of estrogen suppresses the osteo-adipogenic transdifferentiation of osteoblasts via canonical Wnt signaling pathway |
| Q39680232 | Effects of TNF Inhibitors on Parathyroid Hormone and Wnt Signaling Antagonists in Rheumatoid Arthritis. |
| Q42705272 | Effects of naringin on the proliferation and osteogenic differentiation of human amniotic fluid-derived stem cells |
| Q40703352 | Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis. |
| Q53593434 | Effects of the 1, 4-dihydropyridine L-type calcium channel blocker benidipine on bone marrow stromal cells. |
| Q37677831 | Endocrinology of anorexia nervosa in young people: recent insights |
| Q92798626 | Erythropoietin enhances osteogenic differentiation of human periodontal ligament stem cells via Wnt/β-catenin signaling pathway |
| Q41773935 | Excessive Activation of TLR4/NF-κB Interactively Suppresses the Canonical Wnt/β-catenin Pathway and Induces SANFH in SD Rats. |
| Q39255803 | Exploiting the WNT Signaling Pathway for Clinical Purposes |
| Q96609752 | Fibronectin 1 activates WNT/β-catenin signaling to induce osteogenic differentiation via integrin β1 interaction |
| Q38295616 | Focal bone involvement in inflammatory arthritis: the role of IL17. |
| Q42292645 | Genetic architecture of bone quality variation in layer chickens revealed by a genome-wide association study. |
| Q50975008 | Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases. |
| Q48042476 | High doses of vitamin C plus E reduce strength training-induced improvements in areal bone mineral density in elderly men. |
| Q41067642 | Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis. |
| Q45340912 | Higher circulating parathormone is associated with smaller and weaker bones in obese children |
| Q50054792 | Human β-defensin 3-combined gold nanoparticles for enhancement of osteogenic differentiation of human periodontal ligament cells in inflammatory microenvironments |
| Q47723896 | In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls |
| Q40963107 | In vitro effect of microRNA-107 targeting Dkk-1 by regulation of Wnt/β-catenin signaling pathway in osteosarcoma |
| Q35260816 | Increased sclerostin levels after further ablation of remnant estrogen by aromatase inhibitors. |
| Q92604699 | Isopsoralen ameliorates H2O2-induced damage in osteoblasts via activating the Wnt/β-catenin pathway |
| Q37714061 | Isopsoralen-mediated suppression of bone marrow adiposity and attenuation of the adipogenic commitment of bone marrow-derived mesenchymal stem cells |
| Q39289490 | Longitudinal Evaluation of Bone Mineral Density and Bone Metabolism Markers in Patients with Indolent Systemic Mastocytosis Without Osteoporosis. |
| Q92538863 | Loss of Dkk-1 in Osteocytes Mitigates Alveolar Bone Loss in Mice With Periodontitis |
| Q90480255 | MicroRNA Alterations for Diagnosis, Prognosis, and Treatment of Osteoporosis: A Comprehensive Review and Computational Functional Survey |
| Q48365103 | Multiple Vertebral Osteonecroses (Kümmell's Disease) After 10 Years on Denosumab: Is Osteocyte Apoptosis to Blame? |
| Q38995852 | Osteocytic cell necrosis is caused by a combination of glucocorticoid-induced Dickkopf-1 and hypoxia |
| Q64086453 | OsteoporosAtlas: a human osteoporosis-related gene database |
| Q93085755 | Overexpression of CAV3 facilitates bone formation via the Wnt signaling pathway in osteoporotic rats |
| Q43787080 | Pigment epithelium derived factor suppresses expression of Sost/Sclerostin by osteocytes: implication for its role in bone matrix mineralization. |
| Q47426896 | Polygonum multiflorm alleviates glucocorticoid‑induced osteoporosis and Wnt signaling pathway |
| Q47954815 | Possible role of Dickkopf-1 protein in the pathogenesis of tympanosclerosis in a rat model |
| Q38739710 | Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis. |
| Q53031123 | Receptor activator of nuclear factor-κB ligand and sclerostin expression in osteocytes of alveolar bone in rats with ligature-induced periodontitis. |
| Q47106962 | Regulation of osteogenic differentiation by DNA methylation of the dishevelled gene in bone marrow mesenchymal stem cells |
| Q36473294 | Research perspectives: The 2013 AAOS/ORS research symposium on Bone Quality and Fracture Prevention. |
| Q35088791 | Role of WNT16 in the regulation of periosteal bone formation in female mice |
| Q92514218 | Roles of Wnt3a and Dkk1 in experimental periodontitis |
| Q34680463 | Romosozumab for the treatment of osteoporosis |
| Q33651412 | Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice |
| Q36889104 | Sclerostin antibody prevented progressive bone loss in combined ovariectomized and concurrent functional disuse. |
| Q90406658 | Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: A general review |
| Q37282121 | Serum sclerostin levels in renal cell carcinoma patients with bone metastases |
| Q91957948 | Sesamin Promotes Osteoblastic Differentiation and Protects Rats from Osteoporosis |
| Q38598245 | Shen (Kidney)-tonifying principle for primary osteoporosis: to treat both the disease and the Chinese medicine syndrome. |
| Q38818907 | Stapled peptides: providing the best of both worlds in drug development |
| Q37609123 | Tenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivo |
| Q58903531 | Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I |
| Q51725619 | Teriparatide and denosumab combination therapy and skeletal metabolism. |
| Q26748699 | The Regulatory Roles of MicroRNAs in Bone Remodeling and Perspectives as Biomarkers in Osteoporosis |
| Q48215271 | The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis |
| Q26799815 | The role of microRNAs in bone remodeling |
| Q37687575 | Treadmill running exercise prevents senile osteoporosis and upregulates the Wnt signaling pathway in SAMP6 mice |
| Q58327145 | Treatment of osteoporosis in children with glucocorticoid-treated diseases |
| Q57796694 | Updates in CKD-Associated Osteoporosis |
| Q33833409 | Wnts' fashion statement: from body stature to dysplasia |
Search more.